Skip to content

Association of transthyretin and retinol-binding protein 4 with risk of classical trigeminal neuralgia: A case-control study

Association of transthyretin and retinol-binding protein 4 with risk of classical trigeminal neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081867
Enrollment
Unknown
Registered
2024-03-14
Start date
2024-03-15
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Classical trigeminal neuralgia

Interventions

Trigeminal neuralgia group:None
Control group:None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years; 2. The C-group: healthy volunteers without neuropathic pain or neurological comorbidities; 3. The T-group: patients diagnosed with classical TN according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria, confirmed by brain magnetic resonance imaging (MRI).

Exclusion criteria

Exclusion criteria: 1. Patients with other types of trigeminal neuralgia, migraine, cluster or primary headache and other neuropathic pain or chronic pain; 2. Patients with familial amyloidosis polyneuropathy, thyroid disease, impaired liver function, cognitive dysfunction, neurodegenerative diseases and psychiatric diseases; 3. Patients with sepsis, coronary heart disease, severe active somatic disease, diabetes mellitus or glucose intolerance, arrhythmia, coagulation disorders, pregnancy; 4. Patients who withdrew from the trial for various reasons.

Design outcomes

Primary

MeasureTime frame
The content of transthyretin in the patient's preoperative serum;The content of retinol-binding protein 4 in the patient's preoperative serum;Aspartate aminotransferase concentrations;Creatinine concentrations;Uric acid concentrations;

Secondary

MeasureTime frame
Transthyretin concentrations in the patient's postoperative serum;Retinol-binding protein 4 concentrations in the patient's postoperative serum;Pain score;Anxiety and depression scores;Sleep quality score;Preoperative carbamazepine dosage;Alanine aminotransferase concentrations;

Countries

China

Contacts

Public ContactFang Gao

The Affiliated Hospital of Xuzhou Medical University

1458089673@qq.com+86 158 6216 8178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026